1-10 of 10
Rocio Garcia-Carbonero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial

Francesca Sarno, Jair Tenorio, Sofia Perea, Laura Medina, Roberto Pazo-Cid, Ignacio Juez, Rocío Garcia-Carbonero, Jaime Feliu, Carmen Guillen-Ponce, Pedro P. Lopez-Casas, Carmen Guerra, Yolanda Duran, José Francisco López-Acosta, Carolina Alonso, Estrella Esquivel, Ana Dopazo, Dipikaa Akshinthala, Senthil K. Muthuswamy, Pablo Lapunzina, Bruno Bockorny, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2): 278–287.
https://doi.org/10.1158/1078-0432.CCR-23-4026
Published: 17 January 2025
View article titled, A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
Open the PDF for A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial in another window
Includes: Supplementary data
Journal Articles

Abstract B038: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study

Valentino Martelli, Joana Vidal, Maria Concepción Fernández-Rodríguez, Pilar García-Alfonso, David Páez, Joan Gibert, Jennifer Linares, Annarita Sibilio, Vicente Alonso, Maria Teresa Cano, Cristina Santos, Gema Duran, Elena Élez, José Luis Manzano, Rocio Garcia-Carbonero, Reyes Ferreiro, Ferran Losa, Estela Pineda, Javier Sastre, Auxiliadora Gomez-España, Rodrigo Toledo, Fernando Rivera, Beatriz Bellosillo, Josep Tabernero, Ramon Ramon Salazar, Enrique Aranda, Clara Montagut
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): B038.
https://doi.org/10.1158/1557-3265.LIQBIOP24-B038
Published: 13 November 2024
View article titled, Abstract B038: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study
Journal Articles

Abstract PR009: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study

Valentino Martelli, Joana Vidal, Maria Concepción Fernández-Rodríguez, Pilar García-Alfonso, David Páez, Joan Gibert, Jennifer Linares, Annarita Sibilio, Vicente Alonso, Maria Teresa Cano, Cristina Santos, Gema Duran, Elena Élez, José Luis Manzano, Rocio Garcia-Carbonero, Reyes Ferreiro, Ferran Losa, Estela Pineda, Javier Sastre, Auxiliadora Gomez-España, Rodrigo Toledo, Fernando Rivera, Beatriz Bellosillo, Josep Tabernero, Ramon Ramon Salazar, Enrique Aranda, Clara Montagut
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): PR009.
https://doi.org/10.1158/1557-3265.LIQBIOP24-PR009
Published: 13 November 2024
View article titled, Abstract PR009: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study
Journal Articles

A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

Paul B. Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, Tony Philip, Carlos Fernandez Martos, Richard Tuli, Almudena Rodriguez-Gutierrez, Mirjam Kuipers, Andreas Becker, Anna Coenen-Stass, Barbara Sarholz, Xiaoli You, Eric D. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 695–702.
https://doi.org/10.1158/1078-0432.CCR-23-1129
Published: 16 February 2024
View article titled, A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Open the PDF for A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer in another window
Includes: Supplementary data
Journal Articles

Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study

Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, Pilar García-Alfonso, David Páez, Marta Guix, Vicente Alonso, Maria Teresa Cano, Cristina Santos, Gema Durán, Elena Elez, José Luís Manzano, Rocío Garcia-Carbonero, Reyes Ferreiro, Ferran Losa, Estela Pineda, Javier Sastre, Fernando Rivera, Beatriz Bellosillo, Josep Tabernero, Enrique Aranda, Ramon Salazar, Clara Montagut, on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (2): 379–388.
https://doi.org/10.1158/1078-0432.CCR-22-1696
Published: 17 January 2023
View article titled, Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study
Open the PDF for Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study in another window
Includes: Supplementary data
Journal Articles

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Joana Vidal, David Casadevall, Beatriz Bellosillo, Carles Pericay, Rocio Garcia-Carbonero, Ferran Losa, Laia Layos, Vicente Alonso, Jaume Capdevila, Javier Gallego, Ruth Vera, Antonieta Salud, Marta Martin-Richard, Miguel Nogué, Elena Cillán, Joan Maurel, Iris Faull, Victoria Raymond, Carlos Fernández-Martos, Clara Montagut
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (10): 2890–2898.
https://doi.org/10.1158/1078-0432.CCR-20-4769
Published: 15 May 2021
View article titled, Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial
Open the PDF for Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial in another window
Includes: Supplementary data
Journal Articles

Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Jaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, Judit Matito, Ginevra Caratù, Francesco M. Mancuso, Stefania Landolfi, Jorge Barriuso, Paula Jimenez-Fonseca, Carlos Lopez Lopez, Rocio Garcia-Carbonero, Jorge Hernando, Ignacio Matos, Nuciforo Paolo, Javier Hernández-Losa, Manel Esteller, Anna Martínez-Cardús, Josep Tabernero, Ana Vivancos, Héctor G. Palmer
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (4): 902–909.
https://doi.org/10.1158/1078-0432.CCR-19-1266
Published: 14 February 2020
View article titled, Epigenetic <em>EGFR</em> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Open the PDF for Epigenetic <em>EGFR</em> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas in another window
Includes: Supplementary data
Journal Articles

Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma

Purificacion Estevez-Garcia, Iker Lopez-Calderero, Sonia Molina-Pinelo, Sandra Muñoz-Galvan, Ana Salinas, Lourdes Gomez-Izquierdo, Antonio Lucena-Cacace, Blanca Felipe-Abrio, Luis Paz-Ares, Rocio Garcia-Carbonero, Amancio Carnero
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3925–3935.
https://doi.org/10.1158/1078-0432.CCR-13-0057
Published: 15 July 2013
View article titled, Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma
Open the PDF for Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma in another window
Includes: Supplementary data
Journal Articles

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial

Josep Tabernero, Rocio Garcia-Carbonero, James Cassidy, Alberto Sobrero, Eric Van Cutsem, Claus-Henning Köhne, Sabine Tejpar, Oleg Gladkov, Irina Davidenko, Ramon Salazar, Liubov Vladimirova, Sergey Cheporov, Olga Burdaeva, Fernando Rivera, Leslie Samuel, Irina Bulavina, Vanessa Potter, Yu-Lin Chang, Nathalie A. Lokker, Peter J. O'Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2541–2550.
https://doi.org/10.1158/1078-0432.CCR-13-0107
Published: 30 April 2013
View article titled, Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
Open the PDF for Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial in another window
Includes: Supplementary data
Journal Articles

Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins

Rocio Garcia-Carbonero, Jeffrey G. Supko
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 641–661.
Published: 01 March 2002
View article titled, Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins
Open the PDF for Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins in another window